ASCO: Promising Start to Pediatric MATCH Trial

Leggi l'articolo originale


Approximately 25% of patients with tumor samples submitted to the Pediatric MATCH program have been matched to an investigational therapy at an interim analysis reported ahead of the ASCO Annual Meeting.

Lascia un commento